Market Newsdesk

Las Vegas, NV, Nov. 25, 2020 (GLOBE NEWSWIRE) — Associa Nevada South announces the addition of two new communities to its expanding client portfolio. 

The first, Cove Community Association, is located along Southern Highlands Parkway and St. Rose Parkway in Las Vegas, NV. Featuring approximately 298 single-family homes, the gated community offers a pool, spa, and a small playground. Located minutes from the Las Vegas strip, Raiders Stadium, and Southern Highlands & M Resort, Cove Community Association is set inside of a shared master-planned community that features homes by Woodside & Pulte. The master community amenities include a resort, two retail centers, recreational facilities, multiple parks, and two medical centers. 

The second newly acquired community is Hillside Homeowners Association. Located in northwest Las Vegas, the property is comprised of approximately 371 single-family homes. Residents enjoy a pool, community park, and basketball court and are a short drive to the Red Rock Canyon National Conservation in Nevada’s Mojave Desert.   

As the new managing agent for both these communities, Associa Nevada South will provide excellent customer service and drive superior results for the board of directors and their valued residents. 

“Associa Nevada South is excited to partner with these new communities and their dedicated boards,” stated Tiffany Dessaints, Associa Nevada South president. “Our team is dedicated to customizing our management services for each client based on their needs, goals, and vision for the future. We are excited to demonstrate that commitment as we serve the new communities, their association board members, and their residents.   

With more than 200 branch offices across North America, Associa delivers unsurpassed management and lifestyle services to nearly five million residents worldwide. Our 10,000+ team members lead the industry with unrivaled education, expertise and trailblazing innovation. For more than 40 years, Associa has provided solutions designed to help communities achieve their vision. To learn more, visit www.associaonline.com.

Stay Connected: 

Like us on Facebook: https://www.facebook.com/associa

Subscribe to the Blog: https://hub.associaonline.com/

Follow us on Twitter: https://twitter.com/associa

Join us on LinkedIn: http://www.linkedin.com/company/associa

Washington, D.C., Nov. 25, 2020 (GLOBE NEWSWIRE) — The U.S. District Court for the Western District of Texas rendered a decision on Tuesday in the case of Michael Cargill v. William Barr, et al., concluding that NCLA client Michael Cargill of Austin, Texas is not entitled to legally possess a bump stock because bump stocks have always been “machineguns” under federal law. NCLA is seeking to overturn the federal ban on bump stocks issued Dec. 26, 2018 by the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and to halt its enforcement, because NCLA believes federal agencies do not have the power to alter federal statutes. NCLA believes that if the federal government wants to outlaw bump stocks, Congress has to do it.

In its ruling the court found that even without reliance on Chevron judicial deference, the “Defendants’ interpretations of the terms ‘single function of the trigger’ and ‘automatically’ in the statutory definition of ‘machinegun’ properly include bump stocks within that definition.” The court reached the conclusion that the statutory language is not vague or ambiguous, even though ATF itself interpreted the language completely differently for well over a decade. In 2010 the ATF conducted a physical examination and test-fire of the Slide Fire bump stock and determined that it “was not regulated as a firearm under the Gun Control Act or the National Firearms Act.” But after the tragic massacre in Las Vegas, Nevada in October of 2017, ATF contradicted its own prior interpretation of the law and disregarded its substantive expertise in the mechanics and operation of firearms in order to alter federal criminal law and ban bump stocks. Because the court decided that the statute is clear, it also refused to apply the rule of lenity in favor of Mr. Cargill.

The Court also held that the Final Rule, which turned an estimated 520,000 bump stock owners around the country into felons overnight, is a “validly issued legislative rule” that does not violate principles of non-delegation or separation of powers. Even the government admitted that the rule was not a legislative rule. NCLA contends that allowing ATF to criminalize bump stocks with its Final Rule exceeds both core constitutional limits on Congress’s ability to delegate legislative power and violates the separation of powers. Because it involves determining the scope of criminal liability, NCLA argues that only Congress could ban the possession of bump stock devices. ATF’s purported exercise of that authority is therefore unconstitutional.

NCLA will appeal the decision in the Cargill case to the U.S. Court of Appeals for the Fifth Circuit. In a related challenge brought by NCLA on behalf of W. Clark Aposhian of Salt Lake City, Utah, the U.S. Court of Appeals for the Tenth Circuit vacated an earlier panel decision on September 4, 2020, and granted NCLA’s petition for rehearing en banc. NCLA will file a reply in the Aposhian case on Thursday, December 5^th.

NCLA released the following statement:

“The court’s decision rests on the dubious conclusion that bump stocks have always been prohibited, even though ATF’s official stance for years was that these devices are not machineguns. No other court in the country has accepted the government’s argument to that effect. We look forward to the Fifth Circuit Court of Appeals swiftly reversing this decision.”

– Caleb Kruckenberg, NCLA Litigation Counsel

For more information visit the case page
here
.

ABOUT NCLA

NCLA is a nonpartisan, nonprofit civil rights group founded by prominent legal scholar Philip Hamburger to protect constitutional freedoms from violations by the Administrative State. NCLA’s public-interest litigation and other pro bono advocacy strive to tame the unlawful power of state and federal agencies and to foster a new civil liberties movement that will help restore Americans’ fundamental rights.

###

Niwot, Colorado., Nov. 25, 2020 (GLOBE NEWSWIRE) — Global Healthcare REIT, Inc. (Currently in a rebranding effort to be renamed Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) announces that upon careful consideration, and after an extensive search, the executive team and the Board have chosen Brandon Thall as the incoming Chief Financial Officer (“CFO”) of the Company with a start date of November 30, 2020.

Selectis Health’s CEO and President, Lance Baller, stated, “We could not be happier with Brandon joining the team; his energy, passion, and ability to operationalize so many value-added ideas and practices makes him the perfect fit to our growing executive team. We look forward to him leading the finance operations and being a part of the leadership team as we continue to move the Company forward during this exciting growth time at the Company.”

Brandon comes to Selectis Health with a broad ranging background and skillset from varied industries, and is optimistic about the work that is needed to be done for proper systems and controls as a publicly held company. “I cannot wait to dig in to work with Lance, the Board, staff and each of our individually operated and managed facilities. I am most excited about Selectis Health’s ability to ensure our local teams, their medical professionals, and the communities they serve are provided with the necessary tools, resources, and infrastructure to ensure all of our residents/patients, team-members, and their families are taken care of with the type of care, access, and love they need, require, and deserve. I am also committed to ensure that the Company going forward will complete and file its SEC reports in a timely fashion.”

Brandon Thall is a graduate of the Daniel’s School of Business at the University of Denver earning his MBA and has held leadership positions in banking and finance, renewable energy, medical insurance, and consumer packaged goods. He is a Colorado native and enjoys spending time in the Colorado wilderness with his wife, Eliza, and their son George, and their families.

For Further Information Contact:
Jacob Taylor
[email protected]

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

All figures in Canadian dollars unless otherwise noted.

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) is pleased to announce that it has completed the second and final tranche of its previously announced best efforts private placement (the “Private Placement”) and issued an additional 250,182 common shares of the Company (the “Shares”) at a purchase price of $2.75 per Share for additional gross proceeds of $688,000.

In total, the Company issued 6,358,381 Shares pursuant to the Private Placement for gross proceeds of $17,485,548. The Private Placement was conducted through a syndicate of agents led by Canaccord Genuity Corp. and including ATB Capital Markets Inc. and Stifel GMP.

The Company used a portion of the net proceeds of the Private Placement to fund the Company’s obligations under a transaction completed on October 30, 2020 whereby the Company will receive the net economic benefits derived under an advisory agreement (the “CIF Advisory Agreement”) entered into between Sierra Crest Investment Management LLC (“SCIM”) and Resource Credit Income Fund (“CIF”) pursuant to which SCIM became the investment adviser to CIF. The net proceeds of the Private Placement will also be used by Mount Logan to continue to invest in public and private debt securities in the North American market in furtherance of its business objective as an alternative asset management company and for general corporate and working capital purposes.

Insiders of the Company subscribed for approximately $1,072,024 worth of Shares in the Private Placement. This participation by insiders constitute “related party transactions” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Shareholders in Special Transactions of which the Company has relied on applicable exemptions from the formal valuation and minority approval requirements.

The Shares issued pursuant to the Private Placement are subject to a hold period of four months from the closing date of the applicable tranche of the Private Placement.

About Mount Logan Capital Inc.

Mount Logan Capital Inc. is an alternative asset management company that is focused on public and private debt securities in the North American market. The Company seeks to source and actively manage loans and other debt-like securities with credit-oriented characteristics. The Company actively sources, evaluates, underwrites, monitors and primarily invests in loans, debt securities, and other credit-oriented instruments that present attractive risk-adjusted returns and present low risk of principal impairment through the credit cycle.

Cautionary Notes

This press release contains forward-looking statements and information within the meaning of applicable securities legislation (collectively referred to herein as “

forward-looking statements

”). Forward-looking statements can be identified by the expressions “seeks”, “expects”, “believes”, “estimates”, “will”, “target” and similar expressions. The forward-looking statements are not historical
facts, but
reflect the current expectations of management of the Company regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward-looking statements. The forward-looking statements discussed in this
press release may include, but are not limited to, the expected use of proceeds from the
Private Placement
;
the
Company receiving substantially all of the economic benefit from the CIF Advisory Agreement in respect of CIF;
and statements relating to the business and future activities of the Company. All forward-looking statements in this press release are qualified by these cautionary statements. The Company believes that the expectations reflected in forward-looking statements are reasonable based on upon the information available at the time such information was given; however, the Company can give no assurance that the actual results or developments will be realized by certain specified dates or at all. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including that the CIF Advisory Agreement is subject to
approval
every two years and such approvals may not be obtained
and if the CIF Advisory Agreement is not renewed the Company’s recourse for repayment
of its loan to SCIM
may be limited, as well as
the matters discussed under “Risk Factors” in the most recently filed annual information form and management’s discussion and analysis for the Company. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. The Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances except as required by securities laws. The forward-looking statements in this press release are made as of the date of this press release.

This
press release
is not, and under no circumstances is it to be construed as, a prospectus or an advertisement, and the communication of this
press release
is not, and under no circumstances is it to be construed as, an offer to sell or a solicitation of an offer to purchase securities of the Company
.
This
press release
is not intended for U
.
S
.
persons
.
The Company’s shares are not and will not be registered under the U
.
S
.
Securities Act of 1933 and the Company is not and will not be registered under the U
.
S
.
Investment Company Act of 1940 (the
“
1940 Act”)
.
U
.
S
.
persons are not permitted to purchase the Company’s shares absent an applicable exemption from registration under each of these Acts. In addition, the number of investors in the United States, or which are U.S.
p
ersons or purchasing for the account or benefit of U.S.
p
ersons, will be limited to such number as is required to comply with an available exemption from the registration requirements of the 1940 Act.

For additional information, please contact:

Ted Gilpin, Chief Financial Officer
[email protected]

Boston, Nov. 25, 2020 (GLOBE NEWSWIRE) — Today, the Centers for Medicare and Medicaid Services (CMS) issued a waiver for Home Hospital services, providing reimbursement for those services and allowing more hospitals the flexibility to provide acute care services in the comfort of patients’ homes. Recent studies conducted within Mass General Brigham have shown that Home Hospital care can improve outcomes, while reducing costs – all while allowing the patient to remain in their home.

“Coverage of home hospital services is an incredibly important step to help bring safe, convenient, and cost-effective care to our patients’ homes,” said Gregg Meyer, MD President of the Community Division and Executive Vice President of Value Based care at Mass General Brigham. “It is an essential part of our system’s work in value-based care and this coverage decision will accelerate our ability to deliver these services to our patients and our communities.” 

Mass General Brigham has nearly 5 years of experience providing home hospital care to its patients. Over the course of the past 2-3 years, Mass General Brigham has offered Home Hospital care to over 1,000 patients. Patients typically eligible for Home Hospital services are those patients that present to the Emergency Department for acute illnesses that require hospitalization including infections, heart failure, asthma and other acute conditions. The decision to deliver care in the home is a decision made between the patient and their care team. Today’s announcement will likely rapidly increase the availability of Home Hospital services across the nation.

In December 2019, physicians within Mass General Brigham conducted the country’s first randomized controlled study of hospital level care at home for acutely ill adults. The study found that the cost of care was nearly 40% lower for home patients than control patients. Home hospital patients had fewer lab orders, used less imaging and had fewer consultations. The team also found that home hospital patients spent a smaller portion of their day sedentary or lying down and had 70% lower readmission rates within 30 days than control patients.

“Our research has shown that we can deliver hospital-level care in our patients’ homes with lower readmission rates, more physical mobility, and a positive patient experience,” said David Levine, MD, MPH, MA,Assistant Professor of Medicine and Medical Director of Strategy and Innovation for Brigham Health Home Hospital. “During these challenging times, a focus on the home is critical. We are so encouraged that CMS is taking this important step, which will allow hospitals across the country to increase their capacity while delivering the care all patients deserve.”

“The patients we have served in Home Hospital during the COVID-19 pandemic have been particularly grateful for the opportunity to be treated in the comfort of their home – especially elderly patients and patients with chronic medical conditions,” said Ryan Thompson, MD, MPH, Director, MGH Home Hospital. “As hospital capacity has become more and more strained, having the ability to send patients home with hospital-level services has been enormously helpful to patients and our hospitals. This program has proven time and again to be a true win-win.”

To learn more about Home Hospital programs at Mass General Brigham, click here and here.

# # #

About Mass General Brigham

Mass General Brigham is an integrated academic healthcare system, uniting great minds in medicine to make life-changing impact for patients in our communities and people around the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a non-profit organization that is committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. For more information, please visit massgeneralbrigham.org.

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to announce they will be in attendance at two invitational investment conferences this month.

B


enzinga Small Cap Conference


Panel Discussion: Tuesday, December 8^th, 2020
Presentation: Tuesday, December 8^th, 2020 – 1:00PM ET

2020 Cantor Fitzgerald Virtual MSO Cannabis Summit
Presentation: Wednesday, December 16^th, 2020 – 3:00PM ET

For more information or to schedule a one-on-one meeting with RWB’s management during these events, please contact Red White & Bloom’s Investor Relations at [email protected].

About Red White & Bloom Brands Inc.

The Company is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major US markets of Michigan, Illinois, California, Arizona, Oklahoma and Massachusetts with respect to cannabis, and the US and internationally for hemp-based CBD products.

For more information about Red White & Bloom Brands Inc., please contact:

Tyler Troup, Managing Director

Circadian Group IR
[email protected]

Visit us on the web: www.RedWhiteBloom.com

Follow us on social media:

Twitter: @rwbbrands
Facebook: @redwhitebloombrands
Instagram: @redwhitebloombrands

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations.  When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information.  The forward-looking statements and information in this press release includes information relating to the new team members expertise and how the Company will benefit from their ability to assist the Company implement its business plan. Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include, among others, the following risks: risks associated with the implementation of the Company’s business plan and matters relating thereto, risks associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key personnel, the potential for conflicts of interest among certain officers or directors, and the volatility of the Company’s common share price and volume.  Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change.  Investors are cautioned against attributing undue certainty to forward-looking statements.

There are a number of important factors that could cause the Company’s actual results to differ materially from those indicated or implied by forward-looking statements and information.  Such factors include, among others, risks related to the Company’s proposed business, such as failure of the business strategy and government regulation; risks related to the Company’s operations, such as additional financing requirements and access to capital, reliance on key and qualified personnel, insurance, competition, intellectual property and reliable supply chains; risks related to the Company and its business generally. The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed a certain progression, which may not be realized.  It has also assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. While the Company may elect to, it does not undertake to update this information at any particular time.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE.  READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.